InvestorsHub Logo
Post# of 4966635
Next 10
Followers 493
Posts 30517
Boards Moderated 3
Alias Born 01/31/2008

Re: Zardiw post# 4962982

Thursday, 03/21/2024 11:35:07 AM

Thursday, March 21, 2024 11:35:07 AM

Post# of 4966635
$BTTX .013 :In February 2024, the FDA granted Better Therapeutics Breakthrough Device Designation for its novel Cognitive Behavioral Therapy (CBT) platform intended to treat adults with metabolic dysfunction-associated steatohepatitis (MASH), formerly known as NASH. We are actively seeking strategic partnerships to expedite the development and commercialization of this therapy.

All posts are my opinion and are not recommendations to buy or sell

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.